Results that matter
We share a vision with our clients to make an impact on the future of human health. And we partner with them to transform therapeutic innovation into market realities.
LATEST NEWS
Productlife Group Acquires Commercial Eyes, Expanding Its Footprint In The APAC Region
ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company
End-to-end expertise
We are the only Australian consultancy to offer specialist knowledge and expertise across the full commercialisation process. We partner with our clients to navigate these pathways throughout the life cycle of their products.
Having the Right QPPV Is Essential to Meeting Pharmacovigilance Obligations
Ensuring the right QPPV is crucial for meeting pharmacovigilance obligations in an evolving landscape of therapeutic goods….
Discover more
Navigating the Complexities: Health Technology Assessment for Rare Diseases
The Commercial Eyes Access team recently had the opportunity to attend a seminar ‘Should we use a different HTA process for rare disease treatments?’ organised by Melbourne University, led by…
Discover more
Extension to TGA Transition Periods for Reclassified Devices and Patient-Matched Devices
The Therapeutic Goods Administration (TGA) recently announced that they have received Government approval to extend the transition period affecting most reclassified devices, as well as patient-matched devices, extending the deadline…
Discover more
Commercial Eyes acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures; and to Elders past and present. It always was and always will be, Aboriginal Land.